Published in Lancet on December 15, 1951
EFFECT OF CORTICOSTEROID THERAPY ON FIBRINOLYSIS IN PATIENTS WITH INFLAMMATORY AND NON-INFLAMMATORY CONDITIONS. Br Med J (1964) 0.93
THE EFFECT OF CITRATE PRESERVATIVES ON ESTIMATING THE WESTERGREN METHOD OF ERYTHROCYTE SEDIMENTATION RATES. J Clin Pathol (1963) 0.75
Haemangioma with coagulopathy: sustained response to prednisone. Arch Dis Child (1975) 0.75
Laboratory aids in steroid therapy. Ann Rheum Dis (1956) 0.75
SJOEGREN'S SYNDROME. A CLINICAL, PATHOLOGICAL, AND SEROLOGICAL STUDY OF SIXTY-TWO CASES. Medicine (Baltimore) (1965) 7.46
Evidence of a diurnal fibrinolytic rhythm; with a simple method of measuring natural fibrinolysis. Clin Sci (Lond) (1957) 7.06
The physiological disposition and metabolic fate of hydrocortisone in man. J Clin Invest (1955) 6.74
THE DEVELOPMENT OF MALIGNANT LYMPHOMA IN THE COURSE OF SJOEGREN'S SYNDROME. Am J Med (1964) 4.07
Posterior subcapsular cataracts induced by corticosteroids in patients with rheumatoid arthritis. JAMA (1960) 3.94
Studies on metacortandralone and metacortandracin in rheumatoid arthritis; antirheumatic potency, metabolic effects, and hormonal properties. J Am Med Assoc (1955) 3.67
Lung lesions in rheumatoid arthritis. Br Med J (1955) 3.03
Arteritis of striated muscle in rheumatoid arthritis. Am J Pathol (1951) 2.86
Major undesirable side-effects resulting from prednisolone and prednisone. J Am Med Assoc (1955) 2.85
A broader spectrum of Sjogren's syndrome and its pathogenetic implications. Ann Rheum Dis (1961) 2.45
Bentonite flocculation test for rheumatoid arthritis. Proc Soc Exp Biol Med (1958) 2.35
Amyloidosis in rheumatoid arthritis, and significance of unexplained albuminuria; a report of eight cases. Br Med J (1955) 2.28
Vascular lesions in rheumatoid arthritis. J Chronic Dis (1957) 2.15
Observations on the inactivation of fibrinolytic activity in shed blood. Clin Sci (Lond) (1952) 2.14
Vascularity of the early subcutaneous nodule of rheumatoid arthritis. AMA Arch Pathol (1953) 2.11
Synthesis of hyaluronic acid by human synovial tissue slices. Science (1957) 2.09
PHARMACOLOGICAL ENCHANCEMENT OF FIBRINOLYTIC ACTIVITY OF BLOOD. J Clin Pathol (1964) 1.98
The clinical effects of cortisone and ACTH on rheumatic diseases. Bull N Y Acad Med (1951) 1.98
Ulnar deviation of the fingers. Ann Rheum Dis (1951) 1.91
The fibrinolytic activity of normal blood. Br J Haematol (1955) 1.87
Effects of intra-articular hydrocortisone acetate on the clinical course, aminotripeptidase activity and other changes in the synovial fluid in rheumatoid arthritis. Ann Rheum Dis (1952) 1.76
Cataracts in rheumatoid arthritis patients treated with corticosteroids. Description and differential diagnosis. Arch Ophthalmol (1961) 1.74
ARA NOMENCLATURE AND CLASSIFICATION OF ARTHRITIS AND RHEUMATISM (TENTATIVE). Arthritis Rheum (1964) 1.69
Blood fibrinolytic activity in diabetes mellitus and its bearing on ischaemic heart disease and obesity. Br Med J (1963) 1.69
The physiological disposition and metabolic fate of cortisone in man. J Clin Invest (1957) 1.62
Effects in rheumatoid arthritis of hydrocortisone and cortisone injected intra-articularly. AMA Arch Intern Med (1952) 1.60
METHOTREXATE THERAPY IN PSORIATIC ARTHRITIS; DOUBLE-BLIND STUDY ON 21 PATIENTS. JAMA (1964) 1.56
INFLUENCE OF GENETIC AND ENVIRONMENTAL FACTORS ON THE OCCURENCE OF RHEUMATOID ARTHRITIS AND RHEUMATOID FACTOR IN AMERICAN INDIANS. Bull Rheum Dis (1964) 1.54
Studies on dexamethasone, a new synthetic steroid, in rheurheumatoid arthritis: a preliminary report; adrenal cortical, metabolic and early clinical effects. Arthritis Rheum (1958) 1.52
Fibrinolysis by adsorption. Nature (1953) 1.47
Increase of blood fibrinolytic activity by testosterone. Lancet (1962) 1.43
Metabolic effects of metacortandralone and metacortandracin. Ann N Y Acad Sci (1955) 1.39
Observations on new synthetic antirheumatic steroids and critical evaluation of prednisone therapy in rheumatoid arthritis. J Chronic Dis (1957) 1.36
Simple, rapid diagnostic test for rheumatoid arthritis; bentonite flocculation test. J Am Med Assoc (1959) 1.35
SJOEGREN'S SYNDROME AND ITS RELATION TO CONNECTIVE TISSUE DISEASES. J Chronic Dis (1963) 1.33
The anemia of rheumatoid arthritis. Med Clin North Am (1955) 1.24
Cataracts in patients with rheumatic diseases treated with corticosteroids. Further observations. Arch Ophthalmol (1961) 1.23
Evidence of an active fibrinolytic enzyme in the plasma of normal people with observations on inhibition associated with the presence of calcium. Clin Sci (Lond) (1953) 1.21
Sjogren's syndrome. 1. Serologic reactions in patients with Sjogren's syndrome with and without rheumatoid arthritis. Arthritis Rheum (1960) 1.21
Reduction of blood fibrinolytic activity in diabetes mellitus by insulin. Lancet (1959) 1.20
Rheumatism and arthritis: review of American and English literature of recent years. (Tenth Rheumatism Review). I. Ann Intern Med (1953) 1.19
MEASUREMENT OF SPONTANEOUS FIBRINOLYTIC ACTIVITY. J Clin Pathol (1964) 1.18
Origin of blood fibrinolytic activity from veins and its bearing on the fate of venous thrombi. Lancet (1963) 1.17
Evaluation of prolonged cortisone therapy in rheumatiod arthritis: a four-year study. Am J Med (1955) 1.16
Effect of the sulphonylureas on fibrinolysis. Lancet (1960) 1.15
The anti-rheumatic effects of 3-hydroxy-2-phenylcinchoninic acid (HPC) in gout, rheumatic fever, and rheumatoid arthritis. Am J Med Sci (1951) 1.11
ANTINUCLEAR AND PRECIPITATING AUTO-ANTIBODIES IN SJOEGREN'S SYNDROME. Ann Rheum Dis (1965) 1.10
Rheumatism and arthritis review of American and English literature of recent years (tenth rheumatism review). II. Ann Intern Med (1953) 1.09
A concept of natural fibrinolysis. Lancet (1961) 1.09
The effect of large doses of prednisone on acute rheumatic fever; observations on the treatment of seventeen patients with carditis with a two-year follow-up. AMA J Dis Child (1959) 1.08
CLINICAL, PATHOLOGIC, AND SEROLOGIC STUDIES IN SJOEGREN'S SYNDROME; COMBINED CLINICAL STAFF CONFERENCE AT THE NATIONAL INSTITUTES OF HEALTH. Ann Intern Med (1964) 1.06
Clinical and pathological studies of joint involvement in sarcoidosis. N Engl J Med (1959) 1.05
Cortisone and corticotropin in rheumatic fever and juvenile rheumatoid arthritis. J Am Med Assoc (1952) 1.04
Effect of beer on blood fibrinolytic activity. Lancet (1960) 1.01
A principle for determining prognosis of pregnancy in rheumatic heart disease. J Am Med Assoc (1950) 1.00
The 'fibrinolytic potential' as a simple measure of spontaneous fibrinolysis. J Clin Pathol (1962) 1.00
PHYSIOLOGY AND PHARMACOLOGY OF FIBRINOLYSIS. Br Med Bull (1964) 0.98
STUDIES OF PANCREATIC FUNCTION IN SJOEGREN'S SYNDROME. Ann Intern Med (1964) 0.97
FIBRINOLYTIC EFFECT OF METFORMIN IN CORONARY-ARTERY DISEASE. Lancet (1965) 0.96
Pilot study of intra-articular procaine and hydrocortisone acetate in rheumatoid arthritis. Ann Rheum Dis (1956) 0.95
EFFECT OF CORTICOSTEROID THERAPY ON FIBRINOLYSIS IN PATIENTS WITH INFLAMMATORY AND NON-INFLAMMATORY CONDITIONS. Br Med J (1964) 0.93
THE PHARMACOLOGICAL ENHANCEMENT OF BLOOD FIBRINOLYTIC ACTIVITY WITH SPECIAL REFERENCE TO PHENFORMIN. Acta Cardiol (1964) 0.92
Systemic lupus erythematosus. Circulation (1956) 0.91
Pathogenesis of rupture of extensor tendons at the wrist in rhumatoid arthritis. Arthritis Rheum (1959) 0.90
Salicylates and adrenocortical function in man. Arthritis Rheum (1958) 0.90
Presence of fibrinolytic activity in whole blood, masked by the clotting process. Clin Sci (Lond) (1958) 0.88
Effect of ACTH on water distribution in man as measured by antipyrine, T 1824 and bromide. J Clin Invest (1952) 0.88
Diphenylamine reaction in rheumatoid arthritis. Ann Rheum Dis (1955) 0.87
Spontaneous fibrinolysis. Am J Cardiol (1960) 0.86
The vascularity of the early subcutaneous nodules of rheumatoid arthritis. Bull N Y Acad Med (1953) 0.85
NOMENCLATURE AND CLASSIFICATION OF ARTHRITIS AND RHEUMATISM (TENTATIVE) ACCEPTED BY THE AMERICAN RHEUMATISM ASSOCIATION. Bull Rheum Dis (1964) 0.85
Rheumatoid arthritis: a review of recent advances in our knowledge concerning pathology, diagnosis, and treatment. J Chronic Dis (1955) 0.84
Treatment of systemic lupus erythematosus with prednisone and prednisolone. J Am Med Assoc (1955) 0.84
Disposition of intraarticularly injected cortisone and hydrocortisone. Arthritis Rheum (1959) 0.84
Observations on the use of prednisone in patients with progressive systemic sclerosis (diffuse scleroderma). Ann Intern Med (1956) 0.84
Diabetogenic effect of cortisone and ACTH in a non-diabetic patient with rheumatoid arthritis. Am J Med (1952) 0.84
Clinical uses and hazards of adrenal steroids and their analogues in the management of rheumatic diseases. Bull N Y Acad Med (1957) 0.84
FAMILY AND GENETIC STUDIES OF RHEUMATOID ARTHRITIS AND RHEUMATOID FACTOR IN BLACKFEET INDIANS. Am J Public Health Nations Health (1964) 0.82
Effect of placental "serum" in rheumatoid arthritis. Ann Rheum Dis (1952) 0.81
Arteriovenous difference in natural fibrinolysis. Lancet (1957) 0.80
Effect of ACTH and cortisone on rheumatic carditis; observations on eighteen cases. J Am Med Assoc (1952) 0.79
Effect of acute clinical stress on the levels of hexosamine in serum and its excretion in urine. J Clin Invest (1955) 0.79
Effects of cortisone and ACTH on various types of rheumatic diseases. Trans Assoc Am Physicians (1950) 0.78
Laboratory tests for rheumatic activity. J Chronic Dis (1956) 0.77
A decade of anti-inflammatory steroids, from cortisone to dexamethasone. Summary. Ann N Y Acad Sci (1959) 0.76
Two years' experience of prednisone in rheumatoid arthritis. Br Med J (1957) 0.76
Arthritis in the elderly patient (osteoarthritis). Bull N Y Acad Med (1956) 0.75
Rheumatic fever and the haemolytic streptococcus. Postgrad Med J (1952) 0.75
Effects of corticotropin on body water and electrolytes in patients with rheumatic disease. J Clin Invest (1953) 0.75
Alcaptonuria; clinical staff conference at the National Institutes of Health. Ann Intern Med (1957) 0.75
Rheumatism and arthritis: review of American and English literature of recent years; Twelfth Rheumatism Review. Ann Intern Med (1959) 0.75
Pneumococcic arthritis treated with penicillin; report of six cases. Med Clin North Am (1946) 0.75
The occurrence and significance of vascular lesions in rheumatoid arthritis. Trans Assoc Am Physicians (1957) 0.75
Recognition and treatment of arthritis in the elderly patient. South Med J (1959) 0.75
Ascites following infective hepatitis; a case treated with concentrated plasma. Lancet (1947) 0.75
Dexamethasone: antirheumatic properties, hormonal effects and adverse reactions (a 16 month study). Arthritis Rheum (1960) 0.75
The use of steroids in arthritis and related diseases. Del Med J (1961) 0.75
The rheumatoid factor. Bull Acad Med N J (1963) 0.75
Progressive systemic sclerosis (scleroderma) and dermatomyositis. Med Clin North Am (1958) 0.75
Some plans for the American Rheumatism Association. Arthritis Rheum (1958) 0.75